Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R (February 2006)
Mild gastrointestinal symptoms have been reported at higher levels of intake
Peptide blends Pre-formulated peptide blends like the wolverine stack (BPC-157 + TB-500) or glow peptide blends (TB-500 + BPC-157 + GHK-Cu) come with multiple peptides in a single vial
[32, 33, 34] Depression: Anxiety is often found as a co-morbidity of depression
If the NDA files Q4 2026 and standard review applies, expect an FDA decision around Q4 2027
While subcutaneous injections are generally well tolerated, some patients experience mild to moderate localized reactions at the injection site